CLINICAL TRIALS PROFILE FOR CERLIPONASE ALFA
✉ Email this page to a colleague
All Clinical Trials for cerliponase alfa
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05152914 ↗ | Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 | Enrolling by invitation | David L Rogers, MD | Phase 1/Phase 2 | 2021-11-01 | This is a phase I/II randomized, masked, clinical trial to determine the safety and efficacy of intravitreal administration of cerliponase alfa. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for cerliponase alfa
Condition Name
Clinical Trial Locations for cerliponase alfa
Trials by Country
Clinical Trial Progress for cerliponase alfa
Clinical Trial Phase
Clinical Trial Sponsors for cerliponase alfa
Sponsor Name